World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00603174
Date of registration: 21/11/2007
Primary sponsor: St. Justine's Hospital
Public title: Use of Neurally Adjusted Ventilatory Assist in Infants Respiratory Failure NAVA
Scientific title: Use of Neurally Adjusted Ventilatory Assist in Infants With Acute Respiratory Failure: a Case Study on Servo I
Date of first enrolment: January 2008
Target sample size: 10
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00603174
Study type:  Interventional
Study design:  Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment  
Countries of recruitment
Canada
Contacts
Name:   Jennifer Beck, PhD
Address: 
Telephone:
Email:
Affiliation:  SunnyBrook Health Sciences Centre - Toronto
Name:   Philippe A Jouvet, MD
Address: 
Telephone:
Email:
Affiliation:  Université de Montréal
Key inclusion & exclusion criteria

Inclusion Criteria:

- Intubated and mechanically ventilated infant with respiratory failure < 1 year old)

- Breathing spontaneously, as defined by the ability to trigger the ventilator

- The infant should be breathing on conventional ventilation (SIMV, assist control, or
pressure support) with the following ventilator parameters: pressure plateau < 22 cm
H2O (above PEEP) and PEEP = 6 cm H2O.

Exclusion Criteria:

- Pneumothorax

- Degenerative neuromuscular disease

- Bleeding disorders

- Cardiovascular instability defined by vasopressors infusion (dopamine = 5µg/kg/min,
epinephrine, norepinephrine, dobutamine, vasopressin)

- Cyanotic congenital cardiovascular disease

- Phrenic nerve damage/diaphragm paralysis

- Esophageal perforation

- Use of high frequency oscillatory or jet ventilation

- Contraindication to changing naso gastric tube

- Infant is deemed "too unstable" by the attending physician



Age minimum: N/A
Age maximum: 12 Months
Gender: Both
Health Condition(s) or Problem(s) studied
Respiratory Failure
Intervention(s)
Device: neurally adjusted ventilatory assist (NAVA)
Primary Outcome(s)
patient-ventilator synchrony [Time Frame: up to 28 days]
Secondary Outcome(s)
Number of PEEP or NAVA level adjustments in NAVA mode [Time Frame: up to 28 days]
Number of times back-up rate started (per hour) in NAVA mode [Time Frame: up to 28 days]
Phasic EAdi • Tonic EAdi Phasic EAdi and tonic EAdi [Time Frame: up to 28 days]
Tolerance [Time Frame: up to 28 days]
Secondary ID(s)
HSJ 2537
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Sunnybrook Health Sciences Centre
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history